Kymera Therapeutics price target raised to $152 by Stifel
Stifel raised its price target on Kymera Therapeutics to $152 from $132, maintaining a Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.